These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging. Liu X; Zhou L; Peng W; Wang C; Wang H Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546 [TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging of prostate cancer using a statistical model based on the gamma distribution. Shinmoto H; Oshio K; Tamura C; Soga S; Okamura T; Yamada K; Kaji T; Mulkern RV J Magn Reson Imaging; 2015 Jul; 42(1):56-62. PubMed ID: 25223894 [TBL] [Abstract][Full Text] [Related]
5. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue. Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002 [TBL] [Abstract][Full Text] [Related]
6. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer. Shinmoto H; Tamura C; Soga S; Shiomi E; Yoshihara N; Kaji T; Mulkern RV AJR Am J Roentgenol; 2012 Oct; 199(4):W496-500. PubMed ID: 22997399 [TBL] [Abstract][Full Text] [Related]
7. Non-Gaussian water diffusion kurtosis imaging of prostate cancer. Suo S; Chen X; Wu L; Zhang X; Yao Q; Fan Y; Wang H; Xu J Magn Reson Imaging; 2014 Jun; 32(5):421-7. PubMed ID: 24602826 [TBL] [Abstract][Full Text] [Related]
8. Comparison of stretched-Exponential and monoexponential model diffusion-Weighted imaging in prostate cancer and normal tissues. Liu X; Zhou L; Peng W; Wang H; Zhang Y J Magn Reson Imaging; 2015 Oct; 42(4):1078-85. PubMed ID: 25727776 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer. Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542 [TBL] [Abstract][Full Text] [Related]
11. Apparent diffusion coefficient for prostate cancer imaging: impact of B values. Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621 [TBL] [Abstract][Full Text] [Related]
14. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume. Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849 [TBL] [Abstract][Full Text] [Related]